Researchers analyzed high-resolution MRI scans from two datasets, AMBR and CBA, to measure volumes of specific hypothalamic nuclei in aging and Alzheimer's disease. Participants were sorted by amyloid-beta status and cognitive performance, using PET imaging or cerebrospinal fluid biomarkers to classify Alzheimer's-related changes. The team also tested the reliability of their brain segmentation method and supplemented weaker measurements with molecular data.
nature.com
· 2026-11-18
Researchers led by Lövestam and colleagues injected fibrils of human tau protein into mice and found that the mice's own tau proteins adopted the same misfolded structure as the injected material. The finding, published in Nature, provides direct structural evidence that tau can act as a template converting normal protein into a toxic form, similar to how infectious prion proteins behave.
nature.com
· 2026-09-30
Researchers propose that Alzheimer's disease progresses through distinct molecular and cellular phases marked by biological thresholds, rather than a simple straight-line path from amyloid buildup to Tau pathology to neurodegeneration. At these thresholds, cells lose homeostatic balance and shift behavior, with these altered states spreading unevenly across brain tissue and eventually reaching regions critical to cognition. A key threshold identified is when amyloid triggers Tau phosphorylation, marking the transition from amyloid-driven tissue states to ones dominated by neuronal stress responses.
nature.com
· 2026-09-16